Brief: Simcere Pharmaceutical Says NDA Of Deunoxavir Marboxil Tablets Accepted By NMPA
17/03/2025 01:32
March 17 (Reuters) - Simcere Pharmaceutical Group 2096.HK: NEW DRUG APPLICATION (NDA) OF DEUNOXAVIR MARBOXIL TABLETS WAS ACCEPTED BY NMPA Further company coverage: 2096.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660